Mimedx (MDXG) EPS (Basic) Growth (1y) (2012 - 2026)
Powered by 
Analysis
Mimedx (MDXG) EPS (Basic) Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -47.75% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 25.48% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 41.56% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 43.85% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 14.55% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -25.84% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 42.13% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 13.85% |
| 10 | Mimedx | 665.96 Mn | 530.12 Mn | 44.38 Mn | -254.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -254.26% |
| Mar 31, 2026 | -253.41% |
| Dec 31, 2025 | 103.11% |
| Sep 30, 2025 | 111.05% |
| Jun 30, 2025 | -45.58% |
| Mar 31, 2025 | -22.95% |
| Dec 31, 2024 | -86.85% |
| Sep 30, 2024 | -11.81% |
| Jun 30, 2024 | 84.21% |
| Mar 31, 2024 | 295.26% |
| Dec 31, 2023 | 434.16% |
| Sep 30, 2023 | 168.30% |
| Jun 30, 2023 | 158.65% |
| Mar 31, 2023 | 70.70% |
| Dec 31, 2022 | 668.66% |
| Sep 30, 2022 | -151.80% |
| Jun 30, 2022 | -272.68% |
| Mar 31, 2022 | -20.16% |
| Dec 31, 2021 | 92.41% |
| Sep 30, 2021 | 92.62% |